Stocks in play: Oncolytics Biotech Inc.
Announced that Dr. Matt Coffey , the Company's President and Chief Executive Officer, will be participating in a panel discussion at the Canaccord Genuity Horizons in Oncology Virtual Conference. Oncolytics Biotech Inc. shares T.ONC are trading unchanged at $5.48.
Read:
The Pandemic is Forcing Companies to Keep Employees Happy and Healthy
Top Copper Trader: Prices Could Run to $15000 in the Coming Decade
Nearly 88 Percent of U.S. Companies are Investing in Mental Health Programs
Could Michigan Be the Perfect Entry Point for Cannabis Investors?
The U.S. May Be Ready to Move Forward with Cannabis Legalization